DNM1L and pancreatic neoplasm: Studies have revealed that DRP1 is associated with tumor growth and invasion in pancreatic cancer [10, 11], breast cancer [12], and hepatocellular carcinoma [13], and cancer‐specific mitochondrial dynamics were suggested to be a potential therapeutic target [10, 11].